Vitamin D Consumption Lowers Risk of Death in COVID Patients

Date: 27 September 2020 - 22:21

News ID: ۸۳۲۷۹

BOSTON (Dispatches) --  A new research adds to the growing body of evidence that patients with sufficient levels of Vitamin D are less likely to experience complications and die from COVID-19.
According to the study, published in the journal PLOS ONE, hospitalized COVID-19 patients who were vitamin D sufficient, with a blood level of 25-hydroxyvitamin D of at least 30 ng/mL (a measure of vitamin D status) had a significantly decreased risk for adverse clinical outcomes and death.
In addition, they had lower blood levels of an inflammatory marker (C-reactive protein) and higher blood levels of lymphocytes (a type of immune cell to help fight infection).”This study provides direct evidence that vitamin D sufficiency can reduce the complications, including the cytokine storm (release of too many proteins into the blood too quickly) and ultimately death from COVID-19,” said study author Michael F. Holick from the Boston University in the U.S.
In patients older than 40 years they observed that those patients who were vitamin D sufficient were 51.5 per cent less likely to die from the infection compared to patients who were vitamin D deficient.
Holic believes that being vitamin D sufficient helps to fight consequences from being infected not only with the coronavirus but also other viruses causing upper respiratory tract illnesses including influenza.